Moser Wealth Advisors LLC Decreases Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Moser Wealth Advisors LLC trimmed its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 13.4% during the 4th quarter, Holdings Channel reports. The institutional investor owned 1,452 shares of the exchange traded fund’s stock after selling 225 shares during the period. Moser Wealth Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $131,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Kingsview Wealth Management LLC raised its position in shares of SPDR S&P Biotech ETF by 60.3% in the 4th quarter. Kingsview Wealth Management LLC now owns 6,350 shares of the exchange traded fund’s stock valued at $572,000 after purchasing an additional 2,388 shares during the last quarter. Clientfirst Wealth Management LLC acquired a new position in SPDR S&P Biotech ETF during the 4th quarter valued at approximately $284,000. Golden State Wealth Management LLC purchased a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth $29,000. Strategic Financial Concepts LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth $2,447,000. Finally, Telos Capital Management Inc. grew its holdings in shares of SPDR S&P Biotech ETF by 6.6% during the fourth quarter. Telos Capital Management Inc. now owns 27,816 shares of the exchange traded fund’s stock valued at $2,505,000 after buying an additional 1,710 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of XBI stock opened at $91.24 on Friday. The business has a fifty day moving average of $92.58 and a 200 day moving average of $96.48. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47. The firm has a market capitalization of $6.95 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.